QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

QDEL

21.01

-1.5%↓

NERV

4.3

+5.91%↑

LSTA.US

2.02

-4.72%↓

Search

Virbac SA

Atidarymo kaina

SektoriusSveikatos priežiūra

353 -0.84

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

349

Max

358

Pagrindiniai rodikliai

By Trading Economics

Pajamos

32M

82M

Pardavimai

44M

738M

P/E

Sektoriaus vid.

21.771

105.69

Dividendų pajamingumas

0.42

Pelno marža

11.162

Darbuotojai

6,365

EBITDA

41M

157M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+11.06% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.42%

2.37%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

339M

3B

Ankstesnė atidarymo kaina

353.84

Ankstesnė uždarymo kaina

353

Naujienos nuotaikos

By Acuity

19%

81%

33 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

Virbac SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-11-17 18:59; UTC

Pagrindinės rinkos jėgos

Medicus Pharma Shares Rise After Filing of FDA Priority-Voucher Application

2025-11-17 23:40; UTC

Rinkos pokalbiai

Gold Consolidates Amid Mixed Signals -- Market Talk

2025-11-17 23:34; UTC

Rinkos pokalbiai

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

2025-11-17 22:58; UTC

Rinkos pokalbiai

RBA's Easing Cycle Is Done, TD Securities Says -- Market Talk

2025-11-17 22:46; UTC

Rinkos pokalbiai

Risk Assets Set to Have a Strong 2026 -- Market Talk

2025-11-17 22:06; UTC

Įsigijimai, susijungimai, perėmimai

Constellation Software's Harris Operating Group Completes Agreement To Acquire TECVIA Holding GmbH >CSU.T

2025-11-17 22:02; UTC

Uždarbis

Trip.com Group 3Q Rev $2.6B >TCOM

2025-11-17 22:02; UTC

Uždarbis

Trip.com Group 3Q Adj EPS $3.87 >TCOM

2025-11-17 22:02; UTC

Uždarbis

Trip.com Group 3Q EPS $4.02 >TCOM

2025-11-17 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-11-17 21:40; UTC

Uždarbis

James Hardie Industries 2Q Adj EPS 26c >JHX

2025-11-17 21:40; UTC

Uždarbis

James Hardie Industries 2Q Loss/Shr 10c >JHX

2025-11-17 21:39; UTC

Uždarbis

James Hardie Industries 2Q Sales $1.29B >JHX

2025-11-17 21:38; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025-11-17 21:38; UTC

Uždarbis

XPeng Earnings Beat Wall Street Estimates. Why the Stock Is Falling. -- Barrons.com

2025-11-17 21:10; UTC

Uždarbis

XP Inc. 3Q EPS BRL2.47 >XP

2025-11-17 21:10; UTC

Uždarbis

XP Inc. 3Q Rev BRL4.67B >XP

2025-11-17 20:20; UTC

Rinkos pokalbiai

U.S. Natural Gas Retreats on Milder Weather Outlook -- Market Talk

2025-11-17 20:12; UTC

Rinkos pokalbiai

Easing Underlying Inflation in Canada Seen Leaving Door Open to Rate Cuts Next Year -- Market Talk

2025-11-17 20:12; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-11-17 20:09; UTC

Rinkos pokalbiai

Latest Canadian Inflation Data Supports View BoC is Done Cutting Rates This Cycle -- Market Talk

2025-11-17 19:29; UTC

Rinkos pokalbiai

Gold Slide Continues to Start Week -- Market Talk

2025-11-17 19:16; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025-11-17 18:20; UTC

Įsigijimai, susijungimai, perėmimai

Johnson & Johnson Will Buy Cancer Drugmaker Halda Therapeutics for $3.1 Billion -- Barrons.com

2025-11-17 16:45; UTC

Įsigijimai, susijungimai, perėmimai

Oil Giant TotalEnergies Is Betting Big on Electricity -- Update

2025-11-17 16:16; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Alphabet, Apple, Dell, HPE, Nvidia, XPeng, Tesla, Quantum Computing, and More -- Barrons.com

2025-11-17 16:15; UTC

Uždarbis

Luckin, a Chinese Challenger to Starbucks, Aims to Return to U.S. Stock Market -- WSJ

2025-11-17 15:40; UTC

Įsigijimai, susijungimai, perėmimai

Strategy Is in the Crosshairs of Crypto Investors. It Bought More Bitcoin Anyway. -- Barrons.com

2025-11-17 15:22; UTC

Įsigijimai, susijungimai, perėmimai

Alphabet Stock Pops After Berkshire Takes Stake. Why Buffett Might Be Buying. -- Barrons.com

2025-11-17 15:19; UTC

Rinkos pokalbiai

Deutsche Bank's Strategic Plan Looks a Tad Underwhelming -- Market Talk

Akcijų palyginimas

Kainos pokytis

Virbac SA Prognozė

Kainos tikslas

By TipRanks

11.06% į viršų

12 mėnesių prognozė

Vidutinis 391.5 EUR  11.06%

Aukščiausias 415 EUR

Žemiausias 368 EUR

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Virbac SA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

1

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

303.6 / 306.25Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

33 / 374 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Virbac SA

Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
help-icon Live chat